← Leaderboards
Nicholas R Marsh-Armstrong
Hugo W. Moser Res Inst Kennedy Krieger
$9,876,161
Attributed
$12,064,228
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,064,228 · 11
By mechanism
R01$11,408,938 · 7
R21$606,717 · 2
P41$48,573 · 2
Top collaborators
- Donald J Zack5 shared
- Mark H Ellisman4 shared
Most similar at Hugo W. Moser Res Inst Kennedy Krieger
Same institution · by research overlap
- Jiadi Xu$5,875,655
Others in their field
Top investigators on “Retinal Ganglion Cells”
- David R Williams · University Of Rochester$21,735,700
- David Huang · Cleveland Clinic Lerner Col/Med-Cwru$21,143,307
- Cecilia Sungmin Lee · University Of Washington$17,197,690
- Joshua R Sanes · Washington University$17,158,387
- Dennis Michael Dacey · University Of Washington$16,958,250
- Eduardo J Chichilnisky · Stanford University$16,093,921
Research focus
Retinal Ganglion CellsAxonMolecularGenesProteinsOptic DiskOptic NerveAnimal ModelCellsPathway InteractionsGlaucomaSitePhagocytosisAffectLaboratoriesFutureMouse ModelBaseTransgenic OrganismsAstrocytesInjuryInsightNeurodegenerative DisordersBiological Process
Grant awards (30)
Myeloid cells as mediators of glaucomatous axon self-destruction$423,767
R21 · FY2025 · EY · contact PI
Live imaging-based molecular dissection of a successful vertebrate RGC axonal regeneration program$393,008
R01 · FY2025 · EY · contact PI
Optic nerve head glymphatics and debris clearance in glaucoma$497,023
R01 · FY2022 · EY · contact PI
Optic nerve head glymphatics and debris clearance in glaucoma$528,632
R01 · FY2021 · EY · contact PI
Optic nerve head glymphatics and debris clearance in glaucoma$591,471
R01 · FY2020 · EY · contact PI
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells$443,596
R01 · FY2020 · EY · contact PI
Optic nerve head glymphatics and debris clearance in glaucoma$591,471
R01 · FY2019 · EY · contact PI
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells$443,596
R01 · FY2019 · EY · contact PI
Optic nerve head glymphatics and debris clearance in glaucoma$577,992
R01 · FY2018 · EY · contact PI
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells$443,596
R01 · FY2018 · EY · contact PI
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells$443,595
R01 · FY2017 · EY · contact PI
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells$450,001
R01 · FY2016 · EY · contact PI
Transcellular Degradation of Mitochondria in the Central Nervous System$542,969
R01 · FY2015 · EY · contact PI
Transcellular Degradation of Mitochondria in the Central Nervous System$542,969
R01 · FY2014 · EY · contact PI
Transcellular Degradation of Mitochondria in the Central Nervous System$523,422
R01 · FY2013 · EY · contact PI
Optic nerve head synucleinopathy in glaucoma and the function of gamma-synuclein$383,800
R01 · FY2013 · EY · contact PI
Transcellular Degradation of Mitochondria in the Central Nervous System$542,390
R01 · FY2012 · EY · contact PI
Optic nerve head synucleinopathy in glaucoma and the function of gamma-synuclein$404,000
R01 · FY2012 · EY · contact PI
Optic nerve head synucleinopathy in glaucoma and the function of gamma-synuclein$404,000
R01 · FY2011 · EY · contact PI
GAMMA SYNUCLEIN AGGREGATES AND GLAUCOMA$24,666
P41 · FY2011 · RR · contact PI
Role of a Novel Corepressor in Nuclear Receptor Action$279,836
R01 · FY2010 · DK · contact PI
GAMMA SYNUCLEIN AGGREGATES AND GLAUCOMA$23,907
P41 · FY2010 · RR · contact PI
Role of a Novel Corepressor in Nuclear Receptor Action$282,663
R01 · FY2009 · DK · contact PI
Thyroid hormone & metamorphic ipsilateral projection$383,022
R01 · FY2008 · EY · contact PI
Role of a Novel Corepressor in Nuclear Receptor Action$282,444
R01 · FY2008 · DK · contact PI
Thyroid hormone & metamorphic ipsilateral projection$390,840
R01 · FY2007 · EY · contact PI
Role of a Novel Corepressor in Nuclear Receptor Action$287,311
R01 · FY2007 · DK · contact PI
Thyroid hormone & metamorphic ipsilateral projection$393,041
R01 · FY2006 · EY · contact PI
Thyroid hormone &metamorphic ipsilateral projection$362,250
R01 · FY2005 · EY
Photoreceptor Degeneration Assay-Transgenic Xenopus(RMI)$182,950
R21 · FY2005 · NS